Tiziana Life Sciences – Files Registration Statement on Form F-3 with SEC January 27, 2021 – Posted in: Tiziana Life Sciences (TILS)

27th January, 2021 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Tiziana files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission Tiziana Life Sciences plc (Nasdaq: TLSA /  LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces that it has filed a “universal” shelf registration statement on Form F-3 (File No. 333-252441) (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) in relation to…

Continue reading